Archive - April 2022
EMA and ECDC publish advice on fourth doses of mRNA COVID-19 vaccines
Hundreds of urothelial cancer patients to receive new treatment
Kynos Therapeutics targets inflammation-driven illness
COVID: Why The Current Surge In Cases Is A Problem For Some Countries But Not Others
U.S. National Academy of Sciences creates fund for Ukrainian refugees
Study: How COVID-19 Infects Cells That Lead To Inflammation And Severe Disease
FDA Approves Igalmi (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults
bluebird bio maintains its focus on gene therapy opportunities during structural changes